Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 500,000 | reported | 23 Feb 2023 | tx 7+1,108,200 |
| Alto Neuroscience, Inc. | 131,000 | reported | 11 Feb 2026 | tx 9+765,000−321,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Feb 2026 | GRANT_AWARD | Alto Neuroscience, Inc. | 131,000 | 0.00 USD | deriv |
| 03 Jul 2025 | OTHER | Alto Neuroscience, Inc. | 8,000 | — | deriv |
| 03 Jul 2025 | GRANT_AWARD | Alto Neuroscience, Inc. | 188,000 | — | deriv |
| 03 Jul 2025 | OTHER | Alto Neuroscience, Inc. | 188,000 | — | deriv |
| 03 Jul 2025 | GRANT_AWARD | Alto Neuroscience, Inc. | 125,000 | — | deriv |
| 03 Jul 2025 | GRANT_AWARD | Alto Neuroscience, Inc. | 8,000 | — | deriv |
| 03 Jul 2025 | OTHER | Alto Neuroscience, Inc. | 125,000 | — | deriv |
| 05 Feb 2025 | GRANT_AWARD | Alto Neuroscience, Inc. | 125,000 | 0.00 USD | deriv |
| 20 May 2024 | GRANT_AWARD | Alto Neuroscience, Inc. | 188,000 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Spyre Therapeutics, Inc. | 500,000 | 0.00 USD | deriv |
| 23 Aug 2022 | GRANT_AWARD | Spyre Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |
| 08 Jun 2022 | PURCHASE | Spyre Therapeutics, Inc. | 28,200 | 0.71 USD | |
| 17 Feb 2022 | GRANT_AWARD | Spyre Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 17 Feb 2021 | GRANT_AWARD | Spyre Therapeutics, Inc. | 135,000 | 0.00 USD | deriv |
| 14 Feb 2020 | GRANT_AWARD | Spyre Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 21 Oct 2019 | GRANT_AWARD | Spyre Therapeutics, Inc. | 130,000 | 0.00 USD | deriv |